| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 11 |
| 1 | ADALIMUMAB | 10 |
| 2 | METHOTREXATE | 6 |
| 3 | METHOTREXATE SODIUM | 6 |
| 4 | FOLIC ACID | 4 |
| 5 | INFLIXIMAB-DYYB | 4 |
| 6 | PEMBROLIZUMAB | 4 |
| 7 | PREDNISONE | 4 |
| 8 | APIXABAN | 3 |
| 9 | AZATHIOPRINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | 1 | 0.0076 |
| 1 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 2 | FILGRASTIM-AAFI | 1 | 0.0015 |
| 3 | PSYLLIUM HUSK | 2 | 0.0015 |
| 4 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 5 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 6 | EMPAGLIFLOZIN AND LINAGLIPTIN | 1 | 0.0005 |
| 7 | PRASTERONE | 1 | 0.0004 |
| 8 | CEFUROXIME AXETIL | 1 | 0.0003 |
| 9 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| 1 | Corticosteroid [EPC] | 7 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 6 |
| 3 | Vitamin B12 [EPC] | 5 |
| 4 | Vitamin C [EPC] | 5 |
| 5 | Vitamin D [EPC] | 5 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 7 | Janus Kinase Inhibitor [EPC] | 3 |
| 8 | Kinase Inhibitor [EPC] | 3 |
| 9 | Purine Antimetabolite [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Anticholinergic [EPC] | 1 | 0.0001 |
| 2 | Bile Acid [EPC] | 1 | 0.0000 |
| 3 | Progesterone [EPC] | 1 | 0.0000 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 5 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 6 | Methylxanthine [EPC] | 2 | 0.0000 |
| 7 | Iron Chelator [EPC] | 1 | 0.0000 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 3 | 0.0000 |